Experienced in Osteonecrosis

Sylvain Le Jeune

Bobigny, FR 
Experienced in Osteonecrosis
Bobigny, FR 
OverviewLocationsClinical Research

Overview

Sylvain Le Jeune practices in Bobigny, France. Mr. Le Jeune is rated as an Experienced expert by MediFind in the treatment of Osteonecrosis. His top areas of expertise are Hemolysis, Sickle Cell Disease, Congenital Hemolytic Anemia, and Hemoglobinopathy.

His clinical research consists of co-authoring 28 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Osteonecrosis.

Gender
Male

Locations

Bobigny, France
Other Locations
Paris, France
Creteil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
Enrollment Status: Completed
Publish Date: December 02, 2025
Intervention Type: Drug
Study Drug: Inclacumab
Study Phase: Phase 3
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Enrollment Status: Completed
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: Hydroxycarbamide
Study Phase: Phase 2
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
Enrollment Status: Completed
Publish Date: March 19, 2020
Intervention Type: Drug
View 2 Less Clinical Trials

28 Total Publications

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).
High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).
Journal: BMJ open
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Le Jeune's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile